North America Cardiac Monitoring Devices Market Trends, Size, Segment and Growth by Forecast to 2030

The North America cardiac monitoring devices market is experiencing significant growth, projected to reach US$ 16.43 billion by 2028, up from US$ 10.52 billion in 2021. This growth reflects a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028.

Understanding Cardiac Monitoring Devices

Cardiac event monitors are crucial for tracking the heart’s electrical activity (ECG) and rhythm, especially for symptoms that don’t occur daily. These systems allow real-time monitoring of heart health data, which can be sent directly to doctors. This remote monitoring capability helps reduce the need for frequent in-person doctor visits.

The North America market for these devices is analyzed by type, product type, application, end user, and country (United States, Canada, and Mexico). The market’s growth is driven by trends, technological advancements, and market dynamics, with a focus on the competitive landscape of leading players.

📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00028376

Market Drivers

Increasing Incidence of Cardiovascular Diseases

A major factor fueling the market’s expansion is the rising incidence of cardiovascular diseases (CVDs).

• In the United States, someone experiences a stroke every 40 seconds, and a stroke claims a life every 4 minutes.
• Each year, over 795,000 people in the U.S. are affected by stroke, with approximately 610,000 being first or new strokes.
• The World Health Organization (WHO) estimates around 30 million people worldwide suffer a stroke annually.
• The American Heart Association projects that by 2035, over 130 million people in the U.S. (45.1% of the population) will have some form of CVD.
• In 2018, Coronary Heart Disease (CHD) was the leading cause of CVD-related deaths in the U.S., accounting for 42.1%.
• Key risk factors for CVDs include family history, ethnicity, age, tobacco use, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. Early diagnosis and proactive monitoring play a vital role in preventing most CVD cases, thereby boosting the demand for cardiac monitoring devices.

Rise in Product Launches and Approvals

The market is also significantly boosted by continuous innovation and the approval of new products. Companies are actively investing in research and development, launching advanced devices, and expanding regionally to increase their market share.

Recent notable developments include:

• May 2021: Medtronic plc launched the SonarMed airway monitoring system in the U.S., the first device of its kind to use acoustic technology for real-time endotracheal tube (ETT) obstruction detection and position confirmation.
• July 2021: Medtronic plc received U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm AI algorithms for the LINQ II insertable cardiac monitor (ICM), enhancing the accuracy of cardiac rhythm event data.
• July 2021: Abbott introduced Jot Dx in the U.S., its latest implantable cardiac monitor (ICM), which allows doctors to view all abnormal cardiac rhythm data or focus on “Key Episodes” for simplified arrhythmia rhythm information.
• January 2022: MicroPort CRM received PMDA approval in Japan for Alizea, an implantable pacemaker with Bluetooth connectivity for optimized remote monitoring.
• June 2021: Shenzhen Carewell Electronics Co., Ltd. launched new ECG tablets, NeoEC GT180 and NeoECGS120, supporting connectivity with the AIECG platform for smart diagnostics.

Market Segmentation Insights

Type Insights

The market is segmented into cardiovascular devices, multi-parameter ECG monitors, patient monitoring devices, ambulatory cardiac monitoring, and cardiac monitors.

• In 2020, the cardiovascular devices segment held the largest market share.
• The patient monitoring devices segment is expected to show the highest CAGR between 2021 and 2028, driven by the increasing prevalence of chronic conditions like stroke, coronary heart disease, and sudden cardiac arrest.

Product Type Insights

Product types include portable monitors, smart wearable monitors, and standard monitors.

• In 2020, standard monitors held the largest market share.
• However, the smart wearable monitor segment is projected to grow at the fastest CAGR from 2021 to 2028, due to the increasing adoption of commercial smart wearables for health management and the demand for remote, personalized patient care, especially accelerated by the COVID-19 pandemic.

Application Insights

Applications cover coronary heart diseases, sudden cardiac arrest, stroke, arrhythmia, congenital heart diseases, heart failure, pulmonary hypertension, heart function (HF/LVEDP), pulmonary artery pressure (PA), and others.

• The coronary heart diseases segment held the largest market share in 2020 and is anticipated to remain the largest shareholder by 2028, largely due to the rising prevalence of diabetes, hypertension, and high cholesterol levels.

End User Insights

The market’s end users include hospitals, ambulatory surgery centers (ASCs), and clinics.

• Hospitals held the largest market share in 2020 and are expected to maintain this leading position by 2028, as they are primary centers for treating various cardiovascular diseases.

The North American cardiac monitoring devices market is experiencing significant growth, driven by strategic initiatives like product launches and mergers and acquisitions. Recent innovations highlight this trend:

Recent Product Developments

• Abbott’s Jot Dx Insertable Cardiac Monitor (July 2021): This device was launched in the US to help detect irregular heart rhythms, offering a new tool for cardiac monitoring.
• FDA Approval for AccuRhythm AI (July 2021): The US FDA approved two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor (ICM). These AI-powered algorithms enhance the accuracy of heart rhythm event data, allowing physicians to diagnose and treat aberrant heart rhythms more effectively.

Impact of COVID-19 and the Rise of Remote Monitoring

The COVID-19 pandemic significantly accelerated the demand for cardiac monitoring devices. Prior to the pandemic, routine monitoring in hospitals with heart rate devices and continuous pulse oximetry had already contributed to a reduced death rate from chronic heart diseases. The pandemic, however, created an urgent need to monitor patients in emergency departments and standard medical units, and even at home, to prevent clinical deterioration (e.g., hypoxemia) and maintain hospital capacity.

This shift highlighted the critical need for patient-centric monitoring and therapy. A combination of technological advancements, medical urgency, and supportive payment policies has ushered in a new era of cardiac management, emphasizing remote patient monitoring (RPM). Real-time cardiovascular disease monitoring through wearable medical devices has been proven effective in reducing COVID-19 mortality. As a result, the demand for cardiac monitoring devices is projected to grow continuously due to increasing product approvals and launches in the market.

Market Segmentation

The North America cardiac monitoring devices market is comprehensively analyzed across various segments:

• Type: This includes cardiovascular devices (event monitors, ECG, cardiac catheters, stents, defibrillators, guidewires, pacemakers, heart valves, and others), patient monitoring devices (cardio monitoring devices, anesthesia monitoring devices, hemodynamic monitoring devices, fetal and neonatal monitoring devices, stress management devices, and others), multi-parameter ECG monitors, cardiac monitors (cardiac event monitoring (CEM) holter, extended holter/AECG, and others), ambulatory cardiac monitoring (event recorders, implantable loop recorders, mobile cardiac telemetry, and others), and other specialized devices.
• Product Type: The market is segmented into standard monitors, portable monitors, and smart wearable monitors.
• Application: Key applications include coronary heart diseases, stroke, sudden cardiac arrest, arrhythmia, heart failure, pulmonary hypertension, congenital heart diseases, pulmonary artery pressure (PA), heart function (HF/LVEDP), and other conditions.
• End User: The market serves various end users such as hospitals, clinics, ambulatory surgery centers, cardiac centers, home care, and others.
• Country: The North American market is further segmented by country, encompassing the US, Canada, and Mexico.

Driving Success with Strategic Insights

Strategic insights for the North America Cardiac Monitoring Devices market offer data-driven analysis of the industry landscape, covering current trends, key players, and regional specifics. These insights provide actionable recommendations, enabling stakeholders to:

• Differentiate from competitors by identifying untapped segments or developing unique value propositions.
• Anticipate market shifts by leveraging data analytics.
• Position for long-term success in this dynamic region through a future-oriented perspective.

Ultimately, effective strategic insights empower industry players, whether they are investors, manufacturers, or other stakeholders, to make informed decisions that drive profitability and help them achieve their business objectives within the market.
North America Cardiac Monitoring Devices Regional Insights
The geographic scope of the North America cardiac monitoring devices market encompasses the specific regions where businesses operate and compete. Recognizing local differences—such as varying consumer preferences (for example, preferences in plug types or battery backup duration), economic conditions, and regulatory frameworks—is essential for developing tailored strategies for each market. Companies can increase their market presence by identifying underserved regions or customizing their products to address local needs. Focusing on well-defined markets enables more efficient allocation of resources, targeted marketing efforts, and stronger positioning against local competitors, ultimately fueling growth in these key areas.



About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights